Massivemarkets

SEC Form 4

Moderna, Inc. (MRNA) insider trading

In the 12 months to Oct 23, 2026, 4 MRNA insiders reported open-market sales of $52.7M across 12 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$52.7M
12 filings · 4 insiders
Open-market purchases
$0
0 filings
Pre-arranged sales (10b5-1)
10 of 12
$51.5M of $52.7M sold (98%)

Who traded MRNA, and when

  • Sale
  • Sale, pre-arranged (10b5-1)

MRNA daily close from Oct 23, 2025 to Oct 22, 2026, between $22.36 and $245.81, last $202.63. 12 sale and 0 purchase filings by 4 insiders, marked at their filing dates. Stephen Hoge, President: sold $45.4M across 6 filings, first filed Feb 25, 2026, last Oct 16, 2026. James M. Mock, Chief Financial Officer: sold $4.7M across 1 filing, first filed Sep 14, 2026, last Sep 14, 2026. Shannon Thyme Klinger, Chief Legal Officer: sold $1.4M across 3 filings, first filed Mar 3, 2026, last Sep 3, 2026. Noubar Afeyan, Director: sold $1.1M across 2 filings, first filed Dec 15, 2025, last May 22, 2026.

Largest mark · tap a row for others

Stephen Hoge · President

Sale $17,013,538

78,369 shares at $217.10 avg

Filed Oct 16, 2026 · traded Oct 14

Pre-arranged (10b5-1) · close on filing date $218.01

MRNA daily closelast $202.63

Stephen Hoge · President

$45.4M sold

James M. Mock · Chief Financial Officer

$4.7M sold

Shannon Thyme Klinger · Chief Legal Officer

$1.4M sold

Noubar Afeyan · Director

$1.1M sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Has Moderna, Inc.'s CEO sold stock?

No. Stephane Bancel (CEO) made no open-market sales filed as CEO in the last 12 months.

Open-market trades

12 filings in the last 12 months
InsiderRoleSoldBoughtFilingsPre-arranged (10b5-1)Last filed
Stephen HogePresident$45.4M—6100% of sales
James M. MockChief Financial Officer$4.7M—1100% of sales
Shannon Thyme KlingerChief Legal Officer$1.4M—3100% of sales
Noubar AfeyanDirector$1.1M—2—
Other insider activity (not market trades) · 139 records
  • Option exercises76 records
  • Tax withholding53 records
  • Tax withholding (sold to cover)6 records
  • Grants and awards4 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

Build this yourself

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Agent prompt

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MRNA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.